Recruiting
Effect of Resisted Deep Breathing and Myofascial Release in Postmastectomy
This study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph edema in Postmastectomy.
ClinicalTrials.gov IDNCT07576270
PhaseNA
Enrollment48
SponsorRiphah International University
Age45 Years
SexFEMALE
Conditions studied
Post Mastectomy Lymphedema
About this study
This study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph edema in Postmastectomy.
Interventions
- Other: Resisted Deep Breathing — The total duration of treatment will be 12 weeks and there will be 2 sessions each week
- Other: Myofascial release — The total duration of treatment will be 12 weeks and there will be 2 sessions each week
Primary outcomes
- Spirometer (12th week)
- Circumferential limb measurements (12th week)
- Numerical pain rating scale (NPRS) (12th week)
- Chest Mobility (12th week)
Eligibility information
Inclusion Criteria:
* Radiation therapy and chemotherapy was finished at least three months
* 6 months after mastectomy for breast cancer being diagnosed without lymphedema or with stage 1 lymphedema
* Complete unilateral Mastectomy
* pain and having one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the limited shoulder range of motion.
Exclusion Criteria:
* Presence of shoulder pathologies for which surgical indications exist
* Musculoskeletal injury in adjacent areas (shoulder or neck etc.)
* bilateral surgery for the treatment of breast cancer
* Bilateral lymphadenectomy
* Open wounds on upper limbs
* Circulatory disorders
* History of shoulder surgery for reasons other than breast cancer.
Study locations
- Riphah medical center, Lahore, Punjab Province 6400 Pakistan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.